Prime Minister Justin Trudeau has announced a $1.1 billion strategy for medical research to fight COVID-19.
“The better we understand this virus, its spread and its impact on different people, the better we can fight it and eventually defeat it,” Trudeau said today.
The plan has three components:
- $115 million for research into vaccines and treatments being developed in hospitals and universities.
- $662 million for clinical trials in Canada.
- $350 million to expand national testing and modelling for COVID-19.
Trudeau also announced the creation of a new COVID-19 immunity task force focused on serology testing — blood-based tests used to determine if someone has been exposed to the virus already.
David Naylor, who chaired the committee that reviewed Canada’s response to SARS in 2003, will be on the panel.
Trudeau said the task force will work to determine how many people have COVID-19 beyond those who already have been tested, whether those who’ve recovered are immune and, if so, how long that immunity might last.
One million Canadians will be tested as part of the study over the next two years.
Trudeau said testing is key to the fight against COVID-19. He said 20,000 tests are being done every day.
“Testing must increase even further before we can reopen and restart our normal activities as a country,” he said.
Scientists around the globe are scrambling to come up with tests and treatments to limit the disease and, ultimately, a vaccine to protect against the novel coronavirus, which has killed nearly 2,000 Canadians and almost 200,000 people worldwide.
Today’s measures support previous efforts by the Trudeau government to marshal Canada’s scientific community in the battle against COVID-19.
In mid-March, it committed $275 million to research as part of the first emergency aid package.
That was supplemented later in the month by the creation of a new strategic innovation fund, which provided another $192 million to specific companies and research institutions working on new drugs and vaccines.
The government also has provided $52 million through national granting councils to almost 100 research teams across the country.